The head of the British military facility, dealing with the nerve agent used for poisoning ex-Russian spy Sergei Skripal and his daughter Yulia, on Tuesday said it has "not identified the precise source" of the substance.
Gary Aitkenhead Chief Executive of the Porton Down defence laboratory handling the case investigation said that analysts had identified it (nerve agent) as military-grade Novichok but they had not proved that it was made in Russia as per news outlet France 24.
He further claimed to provide scientific information to the government to help reach to some conclusion.
Aitkenhead then hinted towards the involvement of a state actor in the manufacturing of the nerve agent, while pointing out at the sophisticated methods deployed in the manufacturing of the poisonous agent.
Earlier on Monday, Russia had claimed that spy's poisoning could have been in the British interests.
According to the British government, Skripal and his 33-year-old daughter were exposed to a military-grade nerve agent in the British city of Salisbury on March 4. The father-daughter duo has since been hospitalised. Skripal continues to be in a critical condition whereas Yulia is reportedly out of danger.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
